Эта страница была переведена автоматически, точность перевода не гарантируется. Пожалуйста, обратитесь к английской версии для исходного текста.

Improving Maternal Nutrition in Matlab (IMNiM)

27 апреля 2021 г. обновлено: International Centre for Diarrhoeal Disease Research, Bangladesh

In-home, Intensive Nutrition Counseling to Improve Gestational Weight Gain in Rural Bangladesh: A Cluster-Randomized Controlled Trial

Background: Maternal undernutrition and inadequate gestational weight gain (GWG) are prevalent in rural communities of low- and middle-income countries (LMICs). In Matlab, Bangladesh, 54% of the women fail to gain adequate weight (>4 kg) in the third trimester. Risks associated with inadequate GWG include giving birth to a small-for-gestational age (SGA) infant, low birth weight (LBW) infant, preterm birth (PTB), etc. Few contemporary studies examined the efficacy of nutrition counseling on GWG improvement in LMICs.

Objectives: The primary objective of this study is to assess whether in-home, intensive nutrition counseling during pregnancy, compared to standard antenatal care, could improve GWG among pregnant women in rural Bangladesh.

Methods: This prospective, two-arm, parallel group, equal allocation, open-label, community-based, cluster-randomized controlled trial will be conducted in the icddr,b service area of Matlab, a rural subdistrict of Bangladesh. Clusters will be randomly allocated 1:1 to the intervention arm in which pregnant women will receive monthly in-home, intensive nutrition counseling or the control arm in which pregnant women will receive standard antenatal care as offered by icddr,b and Govt. facilities. Fixed Site Clinics (FSCs) located at the homes of the community health research workers (CHRWs) will act as clusters. Of the 33 FSCs serving rural areas in the icddr,b service area, 20 will be selected randomly and listed. These 20 clinics will then be randomly allocated 1:1 to either an intervention or control group using a computer-generated random allocation sequence. To fulfil the required sample size, each selected CHRW will enroll 16 consecutive pregnancies. Required sample size is 16 women per cluster i.e. 160 women per arm. Eligible participants will be enrolled upon obtaining their consent by 13 and 6/7 weeks of gestation (first trimester) and followed up to 6 weeks postpartum. Trained health workers will visit the homes of the women in the intervention arm once a month and provide nutrition counseling to the women and her influential family members such as mothers, mothers-in-law and husbands. Both intention-to-treat and per-protocol analyses will be performed.

Outcome measures/variables: Proportion of women with inadequate rate of weight gain in the second and third trimester of pregnancy according to the US Institute of Medicine (IOM) 2009 guidelines is the primary outcome variable.

Обзор исследования

Статус

Активный, не рекрутирующий

Тип исследования

Интервенционный

Регистрация (Действительный)

287

Фаза

  • Непригодный

Контакты и местонахождение

В этом разделе приведены контактные данные лиц, проводящих исследование, и информация о том, где проводится это исследование.

Места учебы

      • Chandpur, Бангладеш
        • International Centre for Diarrhoeal Disease Research, Bangladesh

Критерии участия

Исследователи ищут людей, которые соответствуют определенному описанию, называемому критериям приемлемости. Некоторыми примерами этих критериев являются общее состояние здоровья человека или предшествующее лечение.

Критерии приемлемости

Возраст, подходящий для обучения

От 18 лет до 39 лет (Взрослый)

Принимает здоровых добровольцев

Да

Полы, имеющие право на обучение

Женский

Описание

Pregnant women permanently residing in the icddr,b service area of Matlab fulfilling the following criteria:

Inclusion Criteria:

  • aged 18-39 years
  • in the first trimester of pregnancy (before 14 weeks of gestation)
  • BMI 16-24.99 kg/m^2 measured on enrollment
  • willing to participate in the study

Exclusion criteria

  • multiple pregnancy (carrying two or more fetuses)
  • threatened abortion, persistent pervaginal bleeding, or cervical incompetence
  • history of three or more consecutive abortions
  • history of gestational diabetes, macrosomia, gestational hypertension, preeclampsia/eclampsia in a prior pregnancy
  • chronic diseases, such as hypertension, heart disease, chronic obstructive pulmonary disease, chronic kidney disease, chronic liver disease, pancreatic diseases, Crohn's disease, ulcerative colitis, diabetes mellitus, thyroid dysfunction, immunological diseases, malignancy or any other diseases which could impede compliance with the study protocol
  • taking medications known to influence fetal growth, such as insulin, thyroid hormones, glucocorticoids
  • known case of serious psychiatric or behavioral disorders, such as schizophrenia, bipolar disorder
  • scored as moderate or worse on enrollment on any one of the subscales of the Depression, Anxiety and Stress Scales-21 (DASS-21)
  • inability to read or write Bengali
  • belonging to moderately or severely food insecure households as measured by the Household Food Insecurity Access Scale (HFIAS)
  • having a plan to move or deliver outside the study area
  • women practicing some form of vegetarianism
  • women belonging to a household from which another woman is already enrolled in the study

Учебный план

В этом разделе представлена ​​подробная информация о плане исследования, в том числе о том, как планируется исследование и что оно измеряет.

Как устроено исследование?

Детали дизайна

  • Основная цель: Исследования в области здравоохранения
  • Распределение: Рандомизированный
  • Интервенционная модель: Параллельное назначение
  • Маскировка: Нет (открытая этикетка)

Оружие и интервенции

Группа участников / Армия
Вмешательство/лечение
Экспериментальный: Intervention
In this arm, pregnant women, along with their influential family members such as mothers, mothers-in-law, and husbands, will receive monthly in-home, intensive nutrition counseling during the prenatal period.
  • Individualized sessions will be conducted by trained health workers following a standard document (counseling booklet)
  • The messages to be provided through the counseling will be contextualized
  • Sessions will start from the early second trimester and repeat monthly until 36 weeks of gestation
  • Counseling sessions will be conducted at the participant's place
  • Sessions will involve influential family members such as the husband, mother-in-law, mother, and the household head along with the pregnant women
  • Women will receive personalized feedback on their dietary intake pattern (dietary diversity) and the rate of weight gain in each session
  • Sessions will be tailored according to each participant's need and progress
Без вмешательства: Control
Pregnant women in this arm will receive standard antenatal care.

Что измеряет исследование?

Первичные показатели результатов

Мера результата
Мера Описание
Временное ограничение
proportion of women with inadequate rate of weight gain in the second and third trimester of pregnancy according to IOM 2009 guidelines
Временное ограничение: Pre-delivery
Pregnancy trimesters are defined as follows: 1st trimester (0 weeks - 13+6 weeks), 2nd trimester (14 completed weeks - 27+6 weeks), and 3rd trimester (28 completed weeks - childbirth). Rate of weight gain between two time points (trimesters) will be calculated by subtracting the weight measured at the first time point from the weight measured at the second time point and dividing the derived value by the difference in weeks between the two time points.
Pre-delivery

Вторичные показатели результатов

Мера результата
Мера Описание
Временное ограничение
total gestational weight gain (kg)
Временное ограничение: pre-delivery
pre-delivery
rate of weight gain during the 2nd and 3rd trimester (kg/week)
Временное ограничение: pre-delivery
pre-delivery
proportion of women with inadequate total GWG according to IOM criteria
Временное ограничение: pre-delivery
pre-delivery
proportion of women with inadequate total GWG according to local criteria
Временное ограничение: pre-delivery
pre-delivery
proportion of women with inadequate third trimester weight gain according to local criteria
Временное ограничение: pre-delivery
pre-delivery
proportion of preterm births
Временное ограничение: at delivery
childbirth before 37 completed weeks
at delivery
maternal mid-upper arm circumference (MUAC) (mm)
Временное ограничение: baseline, 36 weeks of gestation, at delivery and 6 weeks post-partum
baseline, 36 weeks of gestation, at delivery and 6 weeks post-partum
maternal weight (kg)
Временное ограничение: baseline, 36 weeks of gestation, pre-delivery, at delivery and 6 weeks post-partum
baseline, 36 weeks of gestation, pre-delivery, at delivery and 6 weeks post-partum
maternal body mass index (BMI) (kg/m^2)
Временное ограничение: baseline, 36 weeks of gestation, pre-delivery, at delivery and 6 weeks post-partum
weight and height (at baseline) will be combined to report BMI
baseline, 36 weeks of gestation, pre-delivery, at delivery and 6 weeks post-partum
infant weight (g)
Временное ограничение: at birth (delivery) and after 4 weeks
at birth (delivery) and after 4 weeks
infant length (cm)
Временное ограничение: at birth (delivery) and after 4 weeks
at birth (delivery) and after 4 weeks
infant head circumference (cm)
Временное ограничение: at birth (delivery) and after 4 weeks
at birth (delivery) and after 4 weeks
proportion of low birth weight (< 2500 g) infants
Временное ограничение: at birth (delivery)
at birth (delivery)
proportion of small for gestational age (<10th percentile) infants according to Intergrowth-21st standards
Временное ограничение: at birth (delivery)
at birth (delivery)
proportion of women with pregnancy complications e.g. anemia, preeclampsia
Временное ограничение: at delivery
at delivery
proportion of women with obstetric complications e.g. induction of labor, caesarean section
Временное ограничение: at delivery
at delivery
newborn Apgar score
Временное ограничение: at birth (delivery)
at birth (delivery)
proportion of infants developing morbidity
Временное ограничение: 4 weeks after birth
4 weeks after birth
proportion of infant mortality
Временное ограничение: 4 weeks after birth
4 weeks after birth
dietary diversity score according to the "Guidelines for Measuring Household and Individual Dietary Diversity"
Временное ограничение: baseline, 36 weeks of gestation and 6 weeks post-partum
score range: 0-9; higher scores indicate a better outcome
baseline, 36 weeks of gestation and 6 weeks post-partum
dietary diversity score according to the "Minimum Dietary Diversity for Women: A Guide to Measurement"
Временное ограничение: baseline, 36 weeks of gestation and 6 weeks post-partum
score range: 0-10; higher scores indicate a better outcome
baseline, 36 weeks of gestation and 6 weeks post-partum
proportion of women with inadequate dietary diversity accroding to the "Minimum Dietary Diversity for Women: A Guide to Measurement"
Временное ограничение: baseline, 36 weeks of gestation and 6 weeks post-partum
score range: 0-10; <5 indicates inadequate dietary diversity
baseline, 36 weeks of gestation and 6 weeks post-partum
energy consumption (kcal)
Временное ограничение: baseline, 36 weeks of gestation and 6 weeks post-partum
baseline, 36 weeks of gestation and 6 weeks post-partum
protein consumption (g)
Временное ограничение: baseline, 36 weeks of gestation and 6 weeks post-partum
baseline, 36 weeks of gestation and 6 weeks post-partum
proportion of women with symptoms of depression as measured by Depression, Anxiety, and Stress Scales-21 (DASS-21) scales
Временное ограничение: baseline, 36 weeks of gestation and 6 weeks post-partum
DASS-21 is a validated, widely used, standardized self-report scale with 7 items in each subscale category of Depression, Anxiety, and Stress symptoms. Responses are scored on a 4-point Likert scale ranging from 0 (did not apply to me at all) to 3 (applied to me very much/most of the time), with higher scores indicating higher levels of depression, anxiety or stress.
baseline, 36 weeks of gestation and 6 weeks post-partum
proportion of women with symptoms of anxiety as measured by Depression, Anxiety, and Stress Scales-21 (DASS-21) scales
Временное ограничение: baseline, 36 weeks of gestation and 6 weeks post-partum
DASS-21 is a validated, widely used, standardized self-report scale with 7 items in each subscale category of Depression, Anxiety, and Stress symptoms. Responses are scored on a 4-point Likert scale ranging from 0 (did not apply to me at all) to 3 (applied to me very much/most of the time), with higher scores indicating higher levels of depression, anxiety or stress.
baseline, 36 weeks of gestation and 6 weeks post-partum
proportion of women with symptoms of stress as measured by Depression, Anxiety, and Stress Scales-21 (DASS-21) scales
Временное ограничение: baseline, 36 weeks of gestation and 6 weeks post-partum
DASS-21 is a validated, widely used, standardized self-report scale with 7 items in each subscale category of Depression, Anxiety, and Stress symptoms. Responses are scored on a 4-point Likert scale ranging from 0 (did not apply to me at all) to 3 (applied to me very much/most of the time), with higher scores indicating higher levels of depression, anxiety or stress.
baseline, 36 weeks of gestation and 6 weeks post-partum
healthcare seeking and services utilization e.g. number of prenatal visits
Временное ограничение: at delivery
at delivery

Соавторы и исследователи

Здесь вы найдете людей и организации, участвующие в этом исследовании.

Следователи

  • Главный следователь: S. M. Tafsir Hasan, MBBS, MS, Nutrition and Clinical Services Division, icddr,b

Даты записи исследования

Эти даты отслеживают ход отправки отчетов об исследованиях и сводных результатов на сайт ClinicalTrials.gov. Записи исследований и сообщаемые результаты проверяются Национальной медицинской библиотекой (NLM), чтобы убедиться, что они соответствуют определенным стандартам контроля качества, прежде чем публиковать их на общедоступном веб-сайте.

Изучение основных дат

Начало исследования (Действительный)

15 января 2020 г.

Первичное завершение (Ожидаемый)

30 сентября 2021 г.

Завершение исследования (Ожидаемый)

31 октября 2021 г.

Даты регистрации исследования

Первый отправленный

28 декабря 2019 г.

Впервые представлено, что соответствует критериям контроля качества

27 апреля 2021 г.

Первый опубликованный (Действительный)

3 мая 2021 г.

Обновления учебных записей

Последнее опубликованное обновление (Действительный)

3 мая 2021 г.

Последнее отправленное обновление, отвечающее критериям контроля качества

27 апреля 2021 г.

Последняя проверка

1 апреля 2021 г.

Дополнительная информация

Термины, связанные с этим исследованием

Планирование данных отдельных участников (IPD)

Планируете делиться данными об отдельных участниках (IPD)?

НЕТ

Информация о лекарствах и устройствах, исследовательские документы

Изучает лекарственный продукт, регулируемый FDA США.

Нет

Изучает продукт устройства, регулируемый Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов США.

Нет

Эта информация была получена непосредственно с веб-сайта clinicaltrials.gov без каких-либо изменений. Если у вас есть запросы на изменение, удаление или обновление сведений об исследовании, обращайтесь по адресу register@clinicaltrials.gov. Как только изменение будет реализовано на clinicaltrials.gov, оно будет автоматически обновлено и на нашем веб-сайте. .

Клинические исследования In-home, intensive nutrition counseling

Подписаться